Annals Of Translational Medicine SCIE

國際簡稱：ANN TRANSL MED 參考譯名：轉(zhuǎn)化醫(yī)學(xué)年鑒

主要研究方向：Multiple 預(yù)警期刊審稿周期：

《轉(zhuǎn)化醫(yī)學(xué)年鑒》(Annals Of Translational Medicine)是一本由AME PUBL CO出版的以Multiple為研究特色的國際期刊，發(fā)表該領(lǐng)域相關(guān)的原創(chuàng)研究文章、評論文章和綜述文章，及時報道該領(lǐng)域相關(guān)理論、實踐和應(yīng)用學(xué)科的最新發(fā)現(xiàn)，旨在促進(jìn)該學(xué)科領(lǐng)域科學(xué)信息的快速交流。該期刊是一本未開放期刊。

4區(qū) 中科院分區(qū)
0 年發(fā)文量
未開放 是否OA
2013 創(chuàng)刊年份
24 issues/year 出版周期
English 出版語言

Annals Of Translational Medicine was founded in 2013 and is published bimonthly by the domestic AME Publishing Company group. and observational research, aiming to publish the most practical and up-to-date information in medical research, thereby broadening readers' horizons and promoting the translation between research theory and clinical application.

The editor-in-chief of the journal includes Professor Wang Xuehao (Academician of the Chinese Academy of Engineering), Department of Liver Surgery, The First Affiliated Hospital of Nanjing Medical University, Professor Sun Yinghao (Academician, Chinese Academy of Engineering), Department of Urology, Changhai Hospital, Naval Medical University, and Professor Calvin S. H. Ng, Prince of Wales Hospital, Chinese University of Hong Kong.

[ 查看全部 ]

投稿咨詢加急咨詢

Annals Of Translational Medicine期刊信息

ISSN：2305-5839
出版語言：English
是否OA：未開放
E-ISSN：2305-5847
出版地區(qū)：China
是否預(yù)警：是
出版商：AME PUBL CO
出版周期：24 issues/year
創(chuàng)刊時間：2013
開源占比：0.9949
Gold OA文章占比：99.49%
OA被引用占比：0.7842...
出版國人文章占比：0.41
出版撤稿占比：0.0007...
研究類文章占比：85.09%

Annals Of Translational Medicine中科院評價數(shù)據(jù)

中科院 2022年12月升級版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	4區(qū)	MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué)：研究與實驗 ONCOLOGY 腫瘤學(xué)	4區(qū) 4區(qū)

中科院 2021年12月舊的升級版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	4區(qū)	MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué)：研究與實驗 ONCOLOGY 腫瘤學(xué)	4區(qū) 4區(qū)

中科院 2021年12月基礎(chǔ)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué)：研究與實驗 ONCOLOGY 腫瘤學(xué)	3區(qū) 3區(qū)

中科院 2021年12月升級版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	4區(qū)	MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué)：研究與實驗 ONCOLOGY 腫瘤學(xué)	4區(qū) 4區(qū)

中科院 2020年12月舊的升級版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	是	醫(yī)學(xué)	3區(qū)	MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué)：研究與實驗 ONCOLOGY 腫瘤學(xué)	3區(qū) 3區(qū)

Annals Of Translational Medicine JCR評價數(shù)據(jù)（2023-2024年最新版）

按JIF指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位

Annals Of Translational Medicine歷年數(shù)據(jù)統(tǒng)計

影響因子

中科院分區(qū)

Annals Of Translational Medicine中國學(xué)者發(fā)文選摘

1、EML4-ALK rearrangement of lung large cell neuroendocrine carcinoma: a case report
Author: Chen, Dianjun; Ma, Shuangyue; Sun, Lili; Lang, Yuehong; Yang, Boyan

Journal: ANNALS OF TRANSLATIONAL MEDICINE. 2023; Vol. , Issue , pp. -. DOI: 10.21037/atm-22-6062
2、A pan-cancer analysis of the expression and prognostic significance of PDRG1
Author: Liu, Zhen; Huang, Ketuan; He, Yongfei; Hao, Shuqing; Wei, Zhongliu; Peng, Tao

Journal: ANNALS OF TRANSLATIONAL MEDICINE. 2023; Vol. , Issue , pp. -. DOI: 10.21037/atm-22-5439
3、Research progress and clinical evaluation of histotripsy: a narrative review
Author: Li, Shuaiqi; Wei, Yufan; Zhang, Boya; Li, Xiru

Journal: ANNALS OF TRANSLATIONAL MEDICINE. 2023; Vol. , Issue , pp. -. DOI: 10.21037/atm-22-2578
4、Peroxiredoxin 6 alleviates high glucose-induced inflammation and apoptosis in HK-2 cells by inhibiting TLR4/NF-Kappa B signaling
Author: Wu, Hao; Wu, Rong; Liu, Tianxi; Ma, Hongbin; Xue, Guozhong; Liu, Minglong

Journal: ANNALS OF TRANSLATIONAL MEDICINE. 2023; Vol. , Issue , pp. -. DOI: 10.21037/atm-22-6063
5、Establishment and validation of a diagnostic nomogram for significant histopathologic changes of hepatic injury in HBV- infected patients
Author: Sun, Lin-Lin; Wang, Min; Zhang, Nan-Nan; Chen, Ming-Xia; Li, Yuan-Yuan; Zhang, Shuai; Qin, Cheng-Yong

Journal: ANNALS OF TRANSLATIONAL MEDICINE. 2023; Vol. , Issue , pp. -. DOI: 10.21037/atm-22-5840
6、The prognostic value of neutrophil-to-lymphocyte ratio in de novo stage IV breast cancer: a retrospective cohort study
Author: Shao, Bin; Li, Huiping; Liu, Xiaoran; Song, Guohong; Jiang, Hanfang; Yan, Ying; Zhang, Ruyan; Ran, Ran; Zhang, Jiayang; Liu, Yaxin; Wang, Huan; Wang, Jing; Di, Lijun

Journal: ANNALS OF TRANSLATIONAL MEDICINE. 2023; Vol. , Issue , pp. -. DOI: 10.21037/atm-22-5612
7、The diagnostic value of novel ultrasound attenuation analysis in detecting liver steatosis identified by the controlled attenuation parameter: a diagnostic accuracy study
Author: Jiang, Meijuan; Zhang, Xuanxuan; Wu, Xiaojin; Xu, Zhikang; Pan, Jianlian; He, Huiling; Luo, Yunkai; Chen, Jian

Journal: ANNALS OF TRANSLATIONAL MEDICINE. 2023; Vol. , Issue , pp. -. DOI: 10.21037/atm-22-5821
8、Machine learning screening for Parkinson's disease-related cuproptosis-related typing development and validation and exploration of personalized drugs for cuproptosis genes
Author: Wu, Ji; Qin, Chengjian; Cai, Yuankun; Zhou, Jiabin; Xu, Dongyuan; Lei, Yu; Fang, Guoxing; Chai, Songshan; Xiong, Nanxiang

Journal: ANNALS OF TRANSLATIONAL MEDICINE. 2023; Vol. , Issue , pp. -. DOI: 10.21037/atm-22-5756